Last update 04 Oct 2024
PCAR-019 (PersonGen)
Last update 04 Oct 2024
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms PCAR 019, PCAR-019, PCAR019 |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Related
2
Clinical Trials associated with PCAR-019 (PersonGen)Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
100 Clinical Results associated with PCAR-019 (PersonGen)
Login to view more data
100 Translational Medicine associated with PCAR-019 (PersonGen)
Login to view more data
100 Patents (Medical) associated with PCAR-019 (PersonGen)
Login to view more data
100 Deals associated with PCAR-019 (PersonGen)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia | Phase 2 | CN | 01 Jul 2016 | |
| B-Cell Prolymphocytic Leukemia | Phase 2 | CN | 01 Jul 2016 | |
| CD19 Positive B-Cell Leukemia | Phase 2 | CN | 01 Jul 2016 | |
| Chronic Lymphocytic Leukemia | Phase 2 | CN | 01 Jul 2016 | |
| Diffuse Large B-Cell Lymphoma | Phase 2 | CN | 01 Jul 2016 | |
| Follicular Lymphoma | Phase 2 | CN | 01 Jul 2016 | |
| Mantle-Cell Lymphoma | Phase 2 | CN | 01 Jul 2016 | |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | CN | 09 Jan 2018 | |
| Recurrent B Acute Lymphoblastic Leukemia | IND Approval | CN | 06 Dec 2019 | |
| Refractory B Acute Lymphoblastic Leukemia | IND Approval | CN | 06 Dec 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free